Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them
- PMID: 6332132
Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them
Abstract
In vivo and in vitro, murine peripheral T cells can suppress or "veto" the activation of cytotoxic T lymphocytes directed against antigens presented by those T cells. This suppression is antigen-specific and H-2-restricted. The recognition event initiating this suppression appears to be unidirectional; precursors of cytotoxic T lymphocytes recognize the antigen-bearing veto cell and are thereby inactivated--the veto cell need not recognize the CTL precursor. We show here that 3/3 cytolytic T cell clones can exert veto activity in vitro on normal spleen cells which do not bear antigens the T cell clones can recognize. This suppression results in greatly diminished cytotoxic activity generated during a primary 5-day mixed lymphocyte culture against antigens which the veto cell expresses, but not against third-party antigens present in the same culture. In this same system, a noncytolytic T cell clone will not serve as a source of veto cells. Secondary cytotoxic responses are relatively resistant to the veto cell activity of cloned cytolytic T cells. The cloned veto cells do not suppress the generation of cytotoxic activity directed against antigens they recognize (and presumably carry over via antigen-specific receptors). Cold target competition during the cytotoxic assay has been eliminated as a possible mechanism for T cell clone-induced suppression, and suppression cannot be reversed by the addition to the mixed lymphocyte cultures of supernatants from concanavalin A-activated spleen cells. It is suggested that this mechanism of inactivating primary cytotoxic T lymphocyte responses could play an important role in the maintenance of self-tolerance and in the induction and maintenance of tolerance to allografts.
Similar articles
-
Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.J Immunol. 1984 Oct;133(4):1769-74. J Immunol. 1984. PMID: 6236258
-
Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.J Immunol. 1985 Nov;135(5):2984-9. J Immunol. 1985. PMID: 2413108
-
Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.J Immunol. 1985 Jul;135(1):53-62. J Immunol. 1985. PMID: 3158707
-
Veto suppression: the peripheral way of T cell tolerization.Exp Clin Immunogenet. 1993;10(4):179-88. Exp Clin Immunogenet. 1993. PMID: 7907886 Review.
-
Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.Behring Inst Mitt. 1985 Aug;(77):30-8. Behring Inst Mitt. 1985. PMID: 3936472 Review.
Cited by
-
Immune tolerance and transplantation.Semin Oncol. 2012 Dec;39(6):629-42. doi: 10.1053/j.seminoncol.2012.10.001. Semin Oncol. 2012. PMID: 23206840 Free PMC article. Review.
-
Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity.J Exp Med. 1984 Dec 1;160(6):1702-16. doi: 10.1084/jem.160.6.1702. J Exp Med. 1984. PMID: 6239900 Free PMC article.
-
New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.Immunol Res. 2003;27(2-3):565-74. doi: 10.1385/IR:27:2-3:565. Immunol Res. 2003. PMID: 12857999 Review.
-
Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow.J Exp Med. 1990 Sep 1;172(3):901-9. doi: 10.1084/jem.172.3.901. J Exp Med. 1990. PMID: 2143775 Free PMC article.
-
Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells.J Exp Med. 1990 Sep 1;172(3):719-28. doi: 10.1084/jem.172.3.719. J Exp Med. 1990. PMID: 2388033 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources